VHVI

Lindley named to direct new multidisciplinary Women’s Heart Center

Kathryn Lindley, MD, has joined the Vanderbilt Heart and Vascular Institute as director of the new Women’s Heart Center.

VHVI reaches milestone in cardiac monitor implants

Vanderbilt has reached a new milestone in implanting CardioMEMS remote cardiac monitoring devices.

VHVI offers latest therapies to treat atrial fibrillation

Vanderbilt Heart and Vascular Institute continues to offer the latest in therapies to treat atrial fibrillation (AF or AFib), the most common cardiac arrhythmia.

After receiving his LVAD, patient Brandon Cochran was able to leave the hospital and spend more time with his wife, Amy, and daughters Olivia and Stella.

Novel LVAD allows patient to see family, celebrate milestones

Brandon Cochran, a 39-year-old real estate agent in Louisville, Kentucky, was at home with his family in October 2020 when he went into cardiac arrest. His implanted defibrillator shocked him back to life, and he was hospitalized for seven months.

The Structural Heart and Valve Center team has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves.

Structural Heart and Valve Center reaches procedure milestones

The Structural Heart and Valve Center at Vanderbilt Heart and Vascular Institute (VHVI) has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves, a continuation of a decade of research that is revolutionizing the treatment of these conditions.

Anticoagulation Clinic at Vanderbilt Heart designated an Anticoagulation Center of Excellence

The Anticoagulation Clinic at Vanderbilt Heart and Vascular Institute (VHVI) has been designated an Anticoagulation Center of Excellence by the Anticoagulation Forum, one of only three in Tennessee.

1 2